Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Remote “Attacks” On Implantable Devices Are Improbable – FDA

This article was originally published in The Gray Sheet

Executive Summary

FDA plans to meet with researchers who have shown that implantable cardioverter defibrillators with wireless communication capabilities may be vulnerable to radio-based attacks or interference
Advertisement

Related Content

Wireless Revolution Raises Device Security Fears
FDA Proposes New Cybersecurity Submission Standards For Devices
Medical Device Privacy Consortium Begins Work To Erect Defenses
Hacking Of Wireless Devices Poses Growing Threat, Warns Homeland Security Report
Hacking Threat Merits Closer Look, Industry Acknowledges
Hacking Threat Merits Closer Look, Industry Acknowledges
Harvard’s Maisel Builds An Institute To Spotlight, Explain Device Risks
Harvard’s Maisel Builds An Institute To Spotlight, Explain Device Risks
Advertisement
UsernamePublicRestriction

Register

MT025922

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel